HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Solomon Selected Research

iodixanol (Visipaque)

10/2014Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker.
6/2014Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging.
11/2012Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose.
2/2010Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
6/2009N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Solomon Research Topics

Disease

8Acute Kidney Injury (Acute Renal Failure)
01/2018 - 03/2008
4Chronic Renal Insufficiency
02/2011 - 11/2008
2Body Weight (Weight, Body)
10/2014 - 06/2014
2Hypoxia (Hypoxemia)
01/2014 - 11/2012
2Diabetes Mellitus
02/2010 - 08/2006
1Hematuria
01/2022
1Multiple Sclerosis
12/2021
1Proteinuria
12/2021
1Schizophrenia (Dementia Praecox)
12/2021
1Membranous Glomerulonephritis (Membranous Nephropathy)
12/2021
1Critical Illness (Critically Ill)
12/2017
1Heart Failure
01/2016
1Hypercalcemia (Milk Alkali Syndrome)
02/2011
1Hypocalcemia
02/2011
1Pyelonephritis
02/2009
1Chronic Kidney Failure (Chronic Renal Failure)
10/2007
1Weight Gain
10/2007

Drug/Important Bio-Agent (IBA)

5iodixanol (Visipaque)FDA Link
10/2014 - 06/2009
4Contrast MediaIBA
10/2014 - 03/2008
2AntioxidantsIBA
12/2021 - 01/2018
2Nitric Oxide Synthase (NO Synthase)IBA
06/2015 - 10/2014
2Iohexol (Omnipaque)FDA Link
10/2014 - 06/2014
2IodineIBA
10/2014 - 06/2014
2Ioxaglic Acid (Ioxaglate Meglumine)FDA Link
10/2014 - 06/2014
2Iopamidol (Isovue)FDA LinkGeneric
02/2010 - 06/2009
2Pharmaceutical PreparationsIBA
02/2009 - 08/2006
1Epidermal Growth Factor (EGF)IBA
12/2021
1Insulin (Novolin)FDA Link
12/2021
1Thioctic Acid (Lipoic Acid)IBA
12/2021
1CreatinineIBA
01/2016
1Prostaglandin Antagonists (Prostaglandin Antagonist)IBA
06/2015
1Streptozocin (Streptozotocin)FDA Link
06/2015
1Furosemide (Lasix)FDA LinkGeneric
10/2014
1Indomethacin (Indometacin)FDA LinkGeneric
10/2014
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
10/2014
1Cyclooxygenase InhibitorsIBA
10/2014
1Iothalamic Acid (Iotalamic Acid)FDA Link
06/2014
1Lipocalin-2IBA
06/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014
1Phosphorus (Red Phosphorus)IBA
02/2011
1calcium acetate (Phoslo)FDA LinkGeneric
02/2011
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
06/2009
1Antihypertensive Agents (Antihypertensives)IBA
10/2007

Therapy/Procedure

1Blood Transfusion (Blood Transfusions)
01/2022
1Therapeutics
12/2017
1Fluid Therapy (Oral Rehydration Therapy)
01/2016
1Percutaneous Coronary Intervention
01/2016
1Home Hemodialysis
10/2007
1Renal Dialysis (Hemodialysis)
10/2007